Sign In
Buy CHE
$444.11
+8.04 (+1.84%)
At Close: Jun 23, 2026
Here's Why You Should Retain Chemed (CHE) Stock For Now
04:25pm, Tuesday, 19'th Jul 2022 Zacks Investment Research
Investors are optimistic about Chemed (CHE) owing to the robust demand for Roto-Rooter services and the ongoing rebound in senior housing admissions.
Here's Why You Should Retain Chemed (CHE) Stock For Now
01:55pm, Tuesday, 19'th Jul 2022
Investors are optimistic about Chemed (CHE) owing to the robust demand for Roto-Rooter services and the ongoing rebound in senior housing admissions.
Chemed To Report Second-Quarter 2022 Earnings July 27, Related Conference Call To Be Held On July 28
12:00pm, Wednesday, 06'th Jul 2022
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the second quarter ended June 30, 2022, on Wednesday, July 27, 2022, following th
Chemed (CHE) Surges 3.3%: Is This an Indication of Further Gains?
11:52am, Monday, 20'th Jun 2022 Zacks Investment Research
Chemed (CHE) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Chemed (CHE) Surges 3.3%: Is This an Indication of Further Gains?
09:20am, Monday, 20'th Jun 2022
Chemed (CHE) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Here's Why Investors Should Retain Chemed (CHE) Stock Now
04:20pm, Monday, 13'th Jun 2022 Zacks Investment Research
Strong performance across Chemed's (CHE) Roto-Rooter arm and increased home-based admissions raise investors' confidence.
Here's Why Investors Should Retain Chemed (CHE) Stock Now
01:32pm, Monday, 13'th Jun 2022
Strong performance across Chemed's (CHE) Roto-Rooter arm and increased home-based admissions raise investors' confidence.
Chemed Corporation to Present at the Jefferies 2022 Healthcare Conference
12:00pm, Thursday, 02'nd Jun 2022
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE: CHE) today announced that it will deliver a presentation at the Jefferies 2022 Healthcare Conference on Thursday, June 9, 2022, at approximately
Amedisys (AMED) Down 11% Since Last Earnings Report: Can It Rebound?
05:12pm, Friday, 27'th May 2022 Zacks Investment Research
Amedisys (AMED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Dividend Champion, Contender, And Challenger Highlights: Week Of May 22
05:04am, Sunday, 22'nd May 2022 Seeking Alpha
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.
Chemed Corporation to Present at the 2022 RBC Capital Markets Global Healthcare Conference
12:00pm, Wednesday, 11'th May 2022
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the RBC Capital Markets Global Healthcare Conference on Wednesday, May 18, 2022, at ap
Chemed's (CHE) Q1 Earnings Top Estimates, Margins Increase
03:01pm, Wednesday, 27'th Apr 2022 Zacks Investment Research
In Q1, Chemed's (CHE) VITAS revenue decline was primarily the result of a 4.1% decline in days of care.
Chemed Corporation (CHE) CEO Kevin McNamara on Q1 2022 Results - Earnings Call Transcript
02:45pm, Wednesday, 27'th Apr 2022
Chemed Corporation (NYSE:CHE ) Q1 2022 Earnings Conference Call April 27, 2022 10:00 AM ET Company Participants Kevin McNamara – President and Chief Executive Officer Nick Westfall – President and
Chemed's (CHE) Q1 Earnings Top Estimates, Margins Increase
12:18pm, Wednesday, 27'th Apr 2022
In Q1, Chemed's (CHE) VITAS revenue decline was primarily the result of a 4.1% decline in days of care.
Chemed (CHE) Q1 Earnings Surpass Estimates
10:15pm, Tuesday, 26'th Apr 2022 Zacks Investment Research
Chemed (CHE) delivered earnings and revenue surprises of 6.68% and 1.22%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
